Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:37:48 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:MCRB - SERES THERAPEUTICS - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MCRB - Q10.00.79·0.858.90.825+0.082311.13,978.22,7325,4300.7409  0.8299  0.746.65  0.5419:49:34Apr 0915 min RT 2¢

Recent Trades - Last 10 of 5430
Time ETExPriceChangeVolume
19:49:34Q0.83680.0941150
19:33:14Q0.83690.0942110
19:25:01Q0.83690.094290
19:24:40Q0.83010.08745
19:09:49Q0.830.08731
18:56:11Q0.830.0873275
18:56:11Q0.830.0873100
18:45:38Q0.8250.08231
18:42:28Q0.83550.09281
18:36:17Q0.8250.0823100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-09 07:00U:MCRBNews ReleaseSeres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
2024-03-28 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-19 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-02-28 07:00U:MCRBNews ReleaseSeres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
2024-02-27 07:00U:MCRBNews ReleaseSeres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
2024-02-26 07:00U:MCRBNews ReleaseSeres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
2024-01-17 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-01-09 07:00U:MCRBNews ReleaseSeres Therapeutics Announces VOWST ¢ „ ¢ Commercial Launch Update and US FDA Fast Track Designation for SER-155
2024-01-04 16:00U:MCRBNews ReleaseSeres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-07 19:46U:MCRBNews ReleaseSeres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
2023-11-28 09:18U:MCRBNews ReleaseSeres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
2023-11-21 06:00U:MCRBNews ReleaseFlagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
2023-11-02 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST ¢ „ ¢ Net Sales of $7.6 Million
2023-11-01 10:30U:MCRBNews ReleaseFlagship Pioneering Launches Pioneering Intelligence
2023-10-30 17:30U:MCRBNews ReleaseSeres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST
2023-10-06 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-09-11 06:30U:MCRBNews ReleaseFlagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
2023-09-08 07:00U:MCRBNews ReleaseSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-09-07 10:00U:MCRBNews ReleaseSeres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
2023-08-29 09:00U:MCRBNews ReleaseInvaio achieves first registration for citrus greening solution featuring Trecise ¢ „ ¢ technology